Why the study?
Does low-dose aspirin prevent stroke and death as effectively as high-dose aspirin in patients with TIAs and stroke?
Population
Patients presenting with transient ischemic attacks (TIAs) and stroke
Comparison
Low-dose aspirin (325 mg/day or less) vs High-dose aspirin (greater than 975 mg/day)
Design
Editorial
Authors
Loading...
The authors challenge the prevailing assumption that low-dose aspirin (≤325 mg/day) is as effective as high-dose aspirin (>975 mg/day) for stroke prevention in patients with TIAs and stroke.
Does low-dose aspirin prevent stroke and death as effectively as high-dose aspirin in patients with TIAs and stroke?
The authors challenge the prevailing assumption that low-dose aspirin (≤325 mg/day) is as effective as high-dose aspirin (>975 mg/day) for stroke prevention in patients with TIAs and stroke.
Dyken et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: